FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi
Go back to FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.76 -0.02 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.78 | 52 Week High | $45.58 | |||
| Open | $51.73 | 52 Week Low | $37.82 | |||
| Day High | $51.83 | P/E | N/A | |||
| Day Low | $50.68 | EPS | $0.00 | |||
| Volume | 3,976,766 | |||||
| SmartPros Ltd. (NASDAQ: SPRO) | Delayed: 1.27 -0.11 (7.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.38 | 52 Week High | $3.85 | |||
| Open | $1.38 | 52 Week Low | $1.25 | |||
| Day High | $1.41 | P/E | N/A | |||
| Day Low | $1.25 | EPS | $-0.28 | |||
| Volume | 1,990,403 | |||||
